Table 3. Laboratory outcomes in treatment-naive adults and children on ART.
| Duration on ART (months) | 6 | 12 | 18 | 24 | 30 | 36 | 42 | 48 |
|---|---|---|---|---|---|---|---|---|
| Adults in care and on ART | 7 100 | 3 738 | 1 640 | 651 | 414 | 237 | 139 | 56 |
| On second-line (%) | 0.5 | 1.8 | 3.3 | 3.7 | 4.8 | 9.7 | 10.8 | 17.9 |
| Viral loads done | 5 979 | 3 330 | 1 401 | 573 | 343 | 171 | 93 | 44 |
| Completion (%) | 84.2 | 89.1 | 85.4 | 88.0 | 82.9 | 72.2 | 66.9 | 78.6 |
| < 400 copies/ml (%) | 90.6 | 89.0 | 88.1 | 88.3 | 88.0 | 86.0 | 84.9 | 90.9 |
| 95% CI | 89.8–91.3 | 87.9–90.0 | 86.3–89.7 | 85.4–90.8 | 84.1–91.3 | 79.8–90.8 | 76.0–91.5 | 78.3–97.5 |
| CD4 counts done | 5 972 | 3 335 | 1 380 | 564 | 331 | 168 | 95 | 43 |
| Completion (%) | 84.1 | 89.2 | 84.1 | 86.6 | 80.0 | 70.9 | 68.3 | 76.8 |
| ≥ 200 cells/µl (%) | 62.2 | 74.7 | 82.0 | 86.0 | 90.9 | 88.1 | 88.4 | 95.3 |
| 95% CI | 60.9–63.4 | 73.2–76.2 | 79.9–84.0 | 82.9–88.8 | 87.3–93.8 | 82.2–92.6 | 80.2–94.1 | 84.2–99.4 |
| Children in care and on ART | 1 019 | 597 | 293 | 62 | 41 | 27 | – | – |
| On second-line (%) | 0.1 | 0.7 | 2.0 | 4.8 | 4.9 | 7.4 | – | – |
| Viral loads done | 822 | 531 | 245 | 53 | 28 | 20 | – | – |
| Completion (%) | 80.7 | 88.9 | 83.6 | 85.5 | 68.3 | 74.1 | – | – |
| < 400 copies/ml (%) | 72.7 | 72.3 | 74.7 | 77.4 | 78.6 | 75.0 | – | – |
| 95% CI | 69.6–75.8 | 68.3–76.1 | 68.8–80.0 | 63.8–87.7 | 59.0–91.7 | 50.9–91.3 | – | – |
| CD4 counts done | 807 | 499 | 219 | 35 | 17 | 6 | – | – |
| Completion (%) | 79.2 | 83.6 | 74.7 | 56.5 | 41.5 | 22.2 | – | – |
| > 20% lymphocytes (%) | 57.5 | 71.5 | 74.9 | 85.7 | 88.2 | 83.3 | – | – |
| 95% CI | 54.0–60.9 | 67.4–75.5 | 68.6–80.5 | 69.7–95.2 | 63.6–98.5 | 35.9–99.6 | – | – |
ART, antiretroviral therapy; CI, confidence interval.